Lithium Clinics in Berlin and Dresden: a 50-Year Experience
The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Abstract
Although lithium’s serendipitous discovery as a medication for depression dates back more than 200 years, the first scientific evidence that it prevents mania and depression arose only in the 1960s. However, at that time there was a lack of knowledge about how to administer and monitor lithium therapy safely and properly. The lithium clinics in Dresden and Berlin were remarkably similar in their beginnings in the late 1960s regarding patient numbers and scientific expertise without being aware of one another due to the Iron Curtain separating Germany into a western and eastern part until 1990. In what were initially lithium-care programs run independently from one another, the lithium clinics embedded in academic settings in Dresden and Berlin represent a milestone in the history of psychopharmacological treatment of affective disorders in Germany and trailblazers for today’s lithium therapy. Nowadays, lithium’s clinical applications are unquestioned, such as its use in strategies to prevent mood episodes and suicide, and to treat depression. The extensively documented knowledge of lithium treatment is the fruit of more than 50 years of observing disease courses and of studying side effects and influencing factors of lithium prophylaxis. Its safe and proper administration—in determining the correct indication, baseline and follow-up examinations, recommended dosages, monitoring, or the management of side effects—is well established. Subsequently, both national and international guidelines continue recommending lithium as the gold standard in treating patients with unipolar and bipolar disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, most of the data supporting its utility in preventing suicide related outcomes derives from observational studies of patients followed clinically with lithium 292,293 and some studies have reported conflicting data 294 .”
From Suicide and suicide risk (2019) · cites this paper as [292]
In the citing paper
“Because both medications reduce the risk of suicidal behavior independently of how effective they are for mood and psychosis (225), this indicates potential effects via the diathesis.”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [222]
Citations
Cites
Baastrup, P. C. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730200030005 · Cited by 570 · cited 1×
“1967 was a key year for lithium as a prophylactic agent: ▪ Baastrup and Schou (1967) provided statistical proof of lithium’s relapse-prophylactic effect in a cohort of 88 patients in the course of 1–5 years of lithium treatment [4].”
BackgroundLithium side effects and toxicity: prevalence and management strategies
Gitlin, M. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0068-y · Cited by 531
The suicide prevention effect of lithium: more than 20 years of evidence—a narrative review
Lewitzka, U., Severus, E., Bauer, R., Ritter, P., Müller-Oerlinghausen, B., & Bauer, M. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0032-2 · Cited by 196 · cited 1×
“Today, lithium’s clinical applications are unquestioned, such as its use in strategies to prevent affective relapses and suicide prevention [20, 21], relying on investigations by the protagonists of specialized care in the past.”
BackgroundSelf-citationTondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., Calkin, C. V., Chillotti, C., Hidalgo-Mazzei, D., Manchia, M., et al. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0096-2 · Cited by 125
Self-citationGreil, W., Ludwig‐Mayerhofer, W., Erazo, N., Engel, R. R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., Rudolf, G. A. E., Sauer, H., et al. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02916252 · Cited by 78 · cited 1×
“5 years in approximately 300 bipolar patients: we were heavily surprised by the final results: 4 suicides and 5 suicide attempts had occurred in the carbamazepine group, but none in the lithium group, indicating with remarkable specificity lithium’s antisuicidal effect [19].”
ResultSelf-citationTreatment of lithium intoxication: facing the need for evidence
Haussmann, R., Bauer, M., von Bonin, S., Grof, P., & Lewitzka, U. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0040-2 · Cited by 75
Self-citationAbou-Saleh, M. T., Müller-Oerlinghausen, B., & Coppen, A. J. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0080-x · Cited by 74 · cited 1×
“Today, lithium’s clinical applications are unquestioned, such as its use in strategies to prevent affective relapses and suicide prevention [20, 21], relying on investigations by the protagonists of specialized care in the past.”
BackgroundSelf-citationThe Essential Guide to Lithium Treatment
Bauer, M., & Gitlin, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-31214-9 · Cited by 63 · cited 1×
“Its administration—in determining the indication, the necessary baseline and follow-up examinations, recommended dosages, monitoring, or the management of side effects—is well documented [26, 27].”
BackgroundSelf-citationBocchetta, A., Cabras, F., Pinna, M., Poddighe, A., Sardu, C., Ardau, R., Chillotti, C., & Zompo, M. D. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0089-1 · Cited by 61 · cited 1×
“The deep clinical experience of special patient groups like the elderly on lithium therapy [25] also deserves to be mentioned.”
BackgroundDie Lithiumtherapie Nutzen, Risiken, Alternativen
(1986) · Springer eBooks · doi:10.1007/978-3-642-96935-5 · Cited by 33 · cited 1×
“The second edition appeared in 1997 with Anne Berghöfer as the third editor [18].”
Background
Cited by
Turecki, G., Brent, D. A., Gunnell, D., O’Connor, R. C., Oquendo, M. A., Pirkis, J., & Stanley, B. H. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0121-0 · Cited by 1,074
Bipolar depression: a major unsolved challenge
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0160-1 · Cited by 235
A brain-centric model of suicidal behavior
Mann, J. J., & Rizk, M. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081224 · Cited by 214
Greil, W., de Bardeci, M., Müller-Oerlinghausen, B., Nievergelt, N., Stassen, H. H., Hasler, G., Erfurth, A., Cattapan, K., Rüther, E., Seifert, J., et al. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00313-8 · Cited by 31
“Body weight has to be assessed regularly and frequently by patients and during each visit to their psychiatrists or lithium clinics (Felber et al. 2018; Youn et al. 2022).”
BackgroundSelf-citationLithium salts of Krebs cycle substrates as potential normothymic antioxidant agents
Plotnikov, E. V., Korotkova, E. I., & Voronova, O. A. (2018) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_140_18 · Cited by 13
“[27] This properties are also associated with changing activity of GSK-3 β .”
Unmet Needs in Psychiatry: Bipolar Depression
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_4 · Cited by 8
Duarte, P. M., Miranda, T. S., Marins, L. M., Perez, E. G., Copes, L. G., Tonietto, C. B., Montalli, V. Â. M., Malta, F. S., & Napimoga, M. H. (2020) · Brazilian Dental Journal · doi:10.1590/0103-6440202003595 · Cited by 5
Chapter 49. Treatment of Bipolar Disorder
Strakowski, S. M., & Keck, P. E. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as49 · Cited by 5
Lithium chloride stimulates bone formation in extraction socket repair in rats
Duarte, P. M., Miranda, T. S., Marins, L. M., da Silva, J. R. B., Malta, F. S., Gurgel, B. C. D. V., & Napimoga, M. H. (2022) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-022-01124-4 · Cited by 5
“Lithium chloride (LiCl) is well-established as an effective medication for the prevention and management of unipolar depression, bipolar disorder, and acute mania [1, 2].”
Lithium heute — ein Update seiner Wirksamkeit und Risiken
Müller-Oerlinghausen, B. (2019) · NeuroTransmitter · doi:10.1007/s15016-019-6601-3 · Cited by 3
Self-citationMOGENS SCHOU: 100th anniversary of his birth
Grof, P., & Müller-Oerlinghausen, B. (2018) · International Journal of Bipolar Disorders · doi:10.1186/s40345-018-0138-4 · Cited by 3
Self-citationGreil, W., de Bardeci, M., Müller-Oerlinghausen, B., Nievergelt, N., Stassen, H. H., Hasler, G., Erfurth, A., Cattapan, K., Rüther, E., Seifert, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3139642/v1 · Cited by 2
Self-citationLewitzka, U., & Haußmann, R. (2022) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-021-2201-4 · Cited by 2
Self-citationChagas, A., Feitosa, S. G., de Oliveira, D. F. G., Andrade, K. G. K. V. M., Chaves, J. H., Martins, C., Ferreira, V. C. D. S., Angelino, G. B., Azevedo, S., Almeida, D., et al. (2025) · Brazilian Dental Journal · doi:10.1590/0103-644020256475 · Cited by 1
“However, it has also been shown to be associated with the formation of bone tissue (10) precisely due to the inhibition of GSK3b, favoring the accumulation of β -catenin in the nucleus and, therefore, stimulating osteoblastogenesis (11).”
Greil, W., de Bardeci, M., Müller-Oerlinghausen, B., Nievergelt, N., Stassen, H. H., Hasler, G., Erfurth, A., Cattapan, K., Rüther, E., Seifert, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24312946
Self-citation
Metadata
- Authors
- Felber, W., Bauer, M., Lewitzka, U., & Müller-Oerlinghausen, B.
- Affiliations
- University Hospital Carl Gustav Carus (DE)
- Arzneimittelkommission der deutschen Ärzteschaft (DE)
- Corresponding author
- Lewitzka, Ute
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2018-06-14
- Volume
- 51
- Issue
- 05
- Pages
- 166-171
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2808448496
- Cited by
- 15
- References
- 15
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2020: 4 · 2019: 2 · 2018: 2
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Historical Psychiatry and Medical Practices
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium therapy, bipolar disorder, major depressive disorder, lithium prophylaxis, lithium monitoring, lithium side effects, history of psychopharmacology, Berlin, Dresden, East Germany, West Germany, Iron Curtain
- MeSH terms
- Suicide Prevention, Germany, Humans, Lithium Chloride, Antimanic Agents, Mood Disorders, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.